# FDA 483 - Astellas Pharma Inc. - March 05, 2019

Source: https://www.globalkeysolutions.net/records/483/astellas-pharma-inc/bc58294a-3a70-44de-9115-dcad18a40e5f

> FDA 483 for Astellas Pharma Inc. on March 05, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Astellas Pharma Inc.
- Inspection Date: 2019-03-05
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I

## Related Documents

- [483 - 2025-06-02](https://www.globalkeysolutions.net/records/483/astellas-pharma-inc/0e777650-afc9-4c07-a188-8487371da7f8)
- [483 - 2025-06-06](https://www.globalkeysolutions.net/records/483/astellas-pharma-inc/b484b377-f1c6-41c1-afad-48930d722638)
- [483 - 2025-06-06](https://www.globalkeysolutions.net/records/483/astellas-pharma-inc/376da716-73ce-48b5-8237-321438dbff81)

## Related Officers

- [Dedicated Device Cadre](https://www.globalkeysolutions.net/people/dedicated-device-cadre/693932db-dd86-453f-9b51-a63444b07281)
- [Jose A. Cruz Gonzalez](https://www.globalkeysolutions.net/people/jose-a-cruz-gonzalez/a005cff1-0a90-4396-82c4-de4b0a579374)

Company: https://www.globalkeysolutions.net/companies/astellas-pharma-inc/ad5c1a7d-23cf-412a-88ce-62ab257c3233

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1